Cognition Disorders Completed Phase 2 Trials for Donepezil (DB00843)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01466270Study of Donepezil in Female Breast Cancer Survivors With Cognitive DysfunctionTreatment